Skip to main content
CourtGPT logoCourtGPT
Directory
Law
For Attorneys
Blog
AppointmentsSign InSign Up
§ 69-41-120 — Washington Law | CourtGPT
  1. Home/
  2. Laws/
  3. Washington/
  4. Rcw Dispositions Title 69/
  5. Chapter 69.41 - Legend Drugs—prescription Drugs.69.41.010 - Definitions/
  6. § 69-41-120
Washington Legal Code

§ 69-41-120

Ask AI about this
RCW 69.41.120Prescriptions to contain instruction as to whether or not a therapeutically equivalent generic drug or interchangeable biological product may be substituted—Out-of-state prescriptions—Form—Contents—Procedure.(1) Every drug prescription shall contain an instruction on whether or not a therapeutically equivalent generic drug or interchangeable biological product may be substituted in its place, unless substitution is permitted under a prior-consent authorization.If a written prescription is involved, the prescription must be legible and the form shall have two signature lines at opposite ends on the bottom of the form. Under the line at the right side shall be clearly printed the words 'DISPENSE AS WRITTEN.' Under the line at the left side shall be clearly printed the words 'SUBSTITUTION PERMITTED.' The practitioner shall communicate the instructions to the pharmacist by signing the appropriate line. No prescription shall be valid without the signature of the practitioner on one of these lines. In the case of a prescription issued by a practitioner in another state that uses a one-line prescription form or variation thereof, the pharmacist may substitute a

ractitioner on one of these lines. In the case of a prescription issued by a practitioner in another state that uses a one-line prescription form or variation thereof, the pharmacist may substitute a therapeutically equivalent generic drug or interchangeable biological product unless otherwise instructed by the practitioner through the use of the words 'dispense as written,' words of similar meaning, or some other indication.(2) If an oral prescription is involved, the practitioner or the practitioner's agent shall instruct the pharmacist as to whether or not a therapeutically equivalent generic drug or interchangeable biological product may be substituted in its place. The pharmacist shall note the instructions on the file copy of the prescription.(3) The pharmacist shall note the manufacturer of the drug dispensed on the file copy of a written or oral prescription.(4) The pharmacist shall retain the file copy of a written or oral prescription for the same period of time specified in RCW 18.64.245 for retention of prescription records.[ 2015 c 242 s 2; 2000 c 8 s 3; 1990 c 218 s 1; 1979 c 110 s 2; 1977 ex.s.

a written or oral prescription for the same period of time specified in RCW 18.64.245 for retention of prescription records.[ 2015 c 242 s 2; 2000 c 8 s 3; 1990 c 218 s 1; 1979 c 110 s 2; 1977 ex.s. c 352 s 3.]NOTES:Findings—Intent—2000 c 8: See note following RCW 69.41.010.